Table 3.

COVID-19 severity outcomes.

		OVERALL					CLADRIBINE
Nr	Author	N	Hospitalization	Pneumonia	ICU admission	Death	N	Hospitalization	Death
01	Louapre C.	347	73 (21.0%)	-	4 (1.2%)	12 (3.5%)	3	2 (66.7%)	0 (0.0%)
02	Oreja-Guevara C.	14	1 (7.1%)	1 (7.1%)	0 (0.0%)	0 (0.0%)	14	1 (7.1%)	0 (0.0%)
03	Hervás-García J. V.	19	1 (5.3%)	1 (5.3%)	0 (0.0%)	0 (0.0%)	1^	0 (0.0%)	0 (0.0%)
04	Salter A.	1626	320 (19.7%)	112 (6.9%)	104 (6.4%)	54 (3.3%)	14	1 (7.1%)	0 (0.0%)
05	Czarnowska A.	396	27 (6.8%)	1 (0.3%)	-	1 (0.3%)	5	0 (0.0%)	0 (0.0%)
06	Sormani M. P.	844	96 (11.4%)	99 (11.7%)	38 (4.5%)	13 (1.5%)	11	0 (0.0%)	0 (0.0%)
07	Arrambide G.	326	69 (21.2%)	-	7 (2.1%)	7 (2.1%)	6	0 (0.0%)	0 (0.0%)
08	Spelman T.	476	73 (15.3%)	-	19 (4.0%)	8 (1.7%)	8	1 (12.5%)	0 (0.0%)
09	Drulovic J.	18	0 (0.0%)	5 (27.8%)	0 (0.0%)	0 (0.0%)	11	0 (0.0%)	0 (0.0%)
10	Fragoso Y. D.	73	15 (20.5%)	20 (27.4%)	6 (8.2%)	2 (2.7%)	1^	0 (0.0%)	0 (0.0%)
11	Bsteh G.	126	12 (9.5%)	-	-	4 (3.2%)	2^	0 (0.0%)	0 (0.0%)
12	Perez A. C.	843	340 (40.3%)	-	87 (10.3%)	56 (6.6%)	1^	0 (0.0%)	0 (0.0%)
13	Yavorskaya V.	30	2 (6.7%)	-	-	0 (0.0%)	30	2 (6.7%)	0 (0.0%)
POOLED ESTIMATE
Proportion [95% IC]			14.98 [10.47 – 20.97]	8.40 [2.90 – 21.92]	4.44 [2.76 – 7.06]	2.66 [1.79 – 3.92]		9.36 [4.73 – 17.69]	0.00 [0.00 – 1.17]
I^2 [95% IC]			95.48 [89–23 – 98.70]	97.50 [91.71 – 99.64]	88.61 [62.82 – 96.45]	71.23 [30.81 – 90.50]		0.00 [0.00 – 72.22]	0.00

^{^}Case reports excluded from the meta-analysis